Skip to content

Biosimilars Working Group

  • Home
  • Biologics and Biosimilars
  • Videos
  • News

Videos

Innovator Biologics and Biosimilars

Gastrointestinal Society


 

What is a Biosimilar?

Canadian Arthritis Patient Alliance


 

Understanding Non-Medical Switching: Innovator Biologics and Biosimilars

Alliance for Safe Biologic Medicines


 

WEBINAR: What Is a Biosimilar? The Current Biologics and Biosimilars Landscape in Canada

Canadian Cancer Survivor Network


 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • More
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Skype (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
  • Click to print (Opens in new window)

Key Terms

Biologics are very specific, highly effective medicines made in living cells. They improve health in many complex conditions, including Crohn’s disease, ulcerative colitis, diabetes, rheumatoid arthritis, cancer, osteoporosis, psoriasis, HIV, multiple sclerosis, growth deficiencies, and more.

Biosimilars are products that are similar to an already existing brand-name, original biologic (innovator or originator biologic) but, unlike a generic drug, are not identical.

A WordPress.com Website.
  • Follow Following
    • Biosimilars Working Group
    • Already have a WordPress.com account? Log in now.
    • Biosimilars Working Group
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar